Related Experiment Video
Updated: Mar 24, 2026

2D and 3D Human Induced Pluripotent Stem Cell-Based Models to Dissect Primary Cilium Involvement during Neocortical Development
Published on: March 25, 2022
Modeling Niemann Pick type C1 using human embryonic and induced pluripotent stem cells
M Paulina Ordoñez1, John W Steele2
1Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, United States; Department of Pediatric Gastroenterology, Hepatology, and Nutrition, University of California, San Diego, La Jolla, CA 92037, United States.
Niemann Pick type C1 (NPC1) disease shows neuronal defects in human stem cell-derived neurons. These models are crucial for discovering drugs to treat NPC1, complementing animal studies.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Genetics
Background:
- Niemann Pick type C1 (NPC1) is a genetic disorder.
- NPC1 leads to neurodegeneration.
- Understanding NPC1 pathogenesis is crucial for therapeutic development.
Purpose of the Study:
- To investigate NPC1 disease mechanisms in human stem cell-derived neurons.
- To establish human cellular models for NPC1 research.
- To guide drug discovery for NPC1.
Main Methods:
- Utilizing human embryonic stem cell-derived neurons.
- Employing human induced pluripotent stem cell-derived neurons.
- Analyzing cellular processes underlying neuronal defects in NPC1.
Main Results:
- Demonstrated preferential neuronal defects in NPC1 human cells.
- Provided the first example of NPC1 processes in disease-relevant human neurons.
- Complemented findings from animal models.
Conclusions:
- Human stem cell-derived neurons are vital for studying NPC1.
- Mechanistic studies in relevant human cells are key for drug discovery.
- Stem cell models accelerate the development of new NPC1 therapies.
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
iPS Cell Differentiation

